113729-10-5 Usage
Class
Azabicyclo compounds
Bicyclic Structure
Yes, with a nitrogen atom in the ring
Pharmacological Research
Commonly used
Potential Activity
Neurotransmitter receptor modulator
Therapeutic Effects
Studied for neurological and psychiatric disorders
Additional Properties
Investigated for antiparasitic and antiviral properties
Synthesis
Used as an intermediate in the production of various drugs
Methylester Form
Commonly used in the synthesis of other pharmaceutical compounds
Check Digit Verification of cas no
The CAS Registry Mumber 113729-10-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,7,2 and 9 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 113729-10:
(8*1)+(7*1)+(6*3)+(5*7)+(4*2)+(3*9)+(2*1)+(1*0)=105
105 % 10 = 5
So 113729-10-5 is a valid CAS Registry Number.
113729-10-5Relevant articles and documents
Formation of azomethine ylids by thermolysis of oxazolidines. Study of the reaction in solution and in the gaseous phase
Bureau, R.,Mortier, J.,Joucla, M.
, p. 584 - 596 (2007/10/02)
Thermolysis of oxazolidines leads to azomethine ylids via cycloreversion.In the liquid phase, these intermediates then give 1-3 dipolar cycloaddition; in the gaseous phase, they lead to aziridines.With an alkyl group in position 2, we observed also the formation of enamines.The effect of substituents on both the cycloreversion reaction and the evolution of azomethine ylids was studied.The mechanism of the process tautomerism aziridine -> azomethine ylid -> enamine is discussed.Keywords - azomethine ylids / oxazolidines / cycloreversion / aziridines / enamines / tautomerism
